Onco-Innovations lowers per-unit price of placement

Executive Summary

• Onco‑Innovations Ltd. amended its previously announced non‑brokered private placement, increasing the offering size to up to 3,076,923 units at $0.65 per unit for gross proceeds of up to $2 million.
• Each unit consists of one common share and one warrant exercisable at $0.75 per share for three years; an additional 1 % of the issued shares will be allocated as an administrative fee to a third‑party facilitator.
• Proceeds are earmarked for general corporate and working capital purposes, including operational, R&D, and investor‑relations activities.

Key Details

• Units Offered: Up to 3,076,923 units (each unit = 1 common share + 1 warrant).
• Price per Unit: $0.65.
• Aggregate Gross Proceeds: Up to $2 million.
• Warrant Terms: Each warrant allows purchase of one share at $0.75, exercisable for three years from issuance.
• Administrative Fee Shares: 1.0 % of the total shares issued will be granted to an arm’s‑length third party as compensation for assistance with the placement.
• Finder’s Fees/Warrants: Company may issue additional finders’ fees or warrants on the same terms to parties introducing subscribers.
• Closing Conditions: Subject to receipt of all required regulatory and other approvals; securities will be subject to a hold period of four months and one day.
• Use of Proceeds: General corporate and working‑capital purposes, including pursuit of operational objectives, research & development initiatives, and investor‑relations activities.

Notable Quotes

(No executive quotes were provided in the release.)